Creades delivered a 13% NAV return in 2024, outperforming OMXSGI, with strong contributions from Avanza, Apotea, and Klarna. The company maintains a robust balance sheet, proposes an unchanged dividend, and remains well-positioned for continued growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.